News
Media
PodcastsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Luis D. Pacheco, MD

Advertisement

Articles by Luis D. Pacheco, MD

Society for Maternal-Fetal Medicine Consult Series #51: Thromboembolism prophylaxis for cesarean delivery

ByThe Society for Maternal-Fetal Medicine (SMFM),Luis D. Pacheco, MD,George Saade, MD,Torri D. Metz, MD
October 5th 2020

The risk of venous thromboembolism is particularly high during the postpartum period and especially following cesarean delivery.

A review of new research on maternal hemorrhage

BySteven L. Clark, MD,Luis D. Pacheco, MD
June 1st 2012

A look at new research on one of the leading causes for maternal mortality.

Advertisement

Latest Updated Articles

  • A review of new research on maternal hemorrhage
    A review of new research on maternal hemorrhage

    Published: June 1st 2012 | Updated:



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

Early estrogen use linked to lower disease risks

2

FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms

3

Cynthia Stuenkel, MD, talks evaluating and managing primary ovarian insufficiency

4

Caroline Mitchell, MD, highlights safety and flexibility in treating GSM

5

Elinzanetant demonstrates favorable safety profile in menopausal women, with James A. Simon, MD

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us